Positive association between striatal serotonin level and abnormal involuntary movements in chronic L-DOPA-treated hemiparkinsonian rats
Positive association between striatal serotonin level and abnormal involuntary movements in chronic L-DOPA-treated hemiparkinsonian rats
复制标题
DOI:
10.1016/j.brainresbull.2010.12.006
复制
发表时间:
2011-02-01
影响因子:
3.8
通讯作者:
Koh, Hyun C.
中科院分区:
文献类型:
--
作者:
Gil, Suk J.;Park, Chang H.;Koh, Hyun C.
Although L-DOPA represents the standard of care in Parkinson's disease, long-term treatment may be compromised by L-DOPA-induced dyskinesia (LID), with adverse fluctuations in motor responsiveness and progressive loss of control. Here we show that in rats with 6-hydroxydopamine-induced lesions of the median forebrain bundle, LID correlates with 5-HT levels. Rats were treated with L-DOPA (6 mg/kg) and benserazide (15 mg/kg) daily for 3 weeks to induce the development of abnormal involuntary movements (AIMS).After this chronic L-DOPA treatment, the lesion side of the rats displayed significant changes in striatal dopamine (DA) and 5-HT levels. Striatal DA and 5-hydroxytryptamine (5-HT) levels were inversely correlated, and AIMs were strongly positively correlated DA levels and negatively correlated with 5-HT levels. Axial AIMs were more strongly correlated with DA and 5-HT levels than were the other AIMs subtypes, while locomotive AIMs showed no significant correlation at all. In addition, striatal 5-HT was more strongly (negatively) correlated with the AIMs than striatal DA levels. These results demonstrate that 5-HT contributes to LID and that both striata DA (positively) and 5-HT(negatively) affect the severity of LID. We suggest that by strategic modification of the serotonin system it may be posible to attenuate the adverse effect of chronic L-DOPA therapy. (C) 2010 Elsevier Inc. All rights reserved.